TDOC Teladoc Health, Inc.

NYSE teladochealth.com


$ 6.88 $ -0.29 (-4.04 %)    

Friday, 13-Jun-2025 20:10:41 EDT
QQQ na $ -6.70 (-1.26 %)
DIA na $ -7.49 (-1.74 %)
SPY na $ -6.31 (-1.05 %)
TLT na $ -1.01 (-1.16 %)
GLD na $ 4.23 (1.35 %)
$ 6.86
$ 6.88
-- x --
-- x --
$ 6.88 - $ 6.88
$ 6.35 - $ 15.21
4,471,340
na
1.2B
$ 1.82
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-01-2025 03-31-2025 10-Q
2 02-27-2025 01-01-1970 10-K
3 10-31-2024 09-30-2024 10-Q
4 08-01-2024 06-30-2024 10-Q
5 04-26-2024 03-31-2024 10-Q
6 02-23-2024 12-31-2023 10-K
7 10-27-2023 09-30-2023 10-Q
8 07-28-2023 06-30-2023 10-Q
9 05-02-2023 03-31-2023 10-Q
10 03-01-2023 12-31-2022 10-K
11 11-02-2022 09-30-2022 10-Q
12 08-03-2022 06-30-2022 10-Q
13 05-02-2022 03-31-2022 10-Q
14 02-28-2022 12-31-2021 10-K
15 11-01-2021 09-30-2021 10-Q
16 08-02-2021 06-30-2021 10-Q
17 05-03-2021 03-31-2021 10-Q
18 03-01-2021 12-31-2020 10-K
19 11-06-2020 09-30-2020 10-Q
20 07-30-2020 06-30-2020 10-Q
21 04-29-2020 03-31-2020 10-Q
22 02-26-2020 12-31-2019 10-K
23 10-30-2019 09-30-2019 10-Q
24 07-31-2019 06-30-2019 10-Q
25 04-30-2019 03-31-2019 10-Q
26 02-27-2019 12-31-2018 10-K
27 11-01-2018 09-30-2018 10-Q
28 08-01-2018 06-30-2018 10-Q
29 05-01-2018 03-31-2018 10-Q
30 02-27-2018 12-31-2017 10-K
31 11-01-2017 09-30-2017 10-Q
32 08-02-2017 06-30-2017 10-Q
33 05-08-2017 03-31-2017 10-Q
34 03-01-2017 12-31-2016 10-K
35 10-27-2016 09-30-2016 10-Q
36 08-03-2016 06-30-2016 10-Q
37 05-10-2016 03-31-2016 10-Q
38 03-03-2016 12-31-2015 10-K
39 11-02-2015 09-30-2015 10-Q
40 08-12-2015 06-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 b-of-a-securities-maintains-neutral-on-teladoc-health-lowers-price-target-to-7

B of A Securities analyst Allen Lutz maintains Teladoc Health (NYSE:TDOC) with a Neutral and lowers the price target from $8...

 truist-securities-maintains-hold-on-teladoc-health-lowers-price-target-to-9

Truist Securities analyst Jailendra Singh maintains Teladoc Health (NYSE:TDOC) with a Hold and lowers the price target from ...

 teladocs-outlook-clouds-as-jpmorgan-points-to-uncertainty-in-behavioral-health-margin-pressure

JP Morgan analyst Lisa C. Gill maintained Neutral rating on TDOC with $9 price target, down from $11. Teladoc reports Q1 revenu...

 wells-fargo-maintains-equal-weight-on-teladoc-health-lowers-price-target-to-8

Wells Fargo analyst Stan Berenshteyn maintains Teladoc Health (NYSE:TDOC) with a Equal-Weight and lowers the price target fr...

 canaccord-genuity-maintains-buy-on-teladoc-health-lowers-price-target-to-12

Canaccord Genuity analyst Richard Close maintains Teladoc Health (NYSE:TDOC) with a Buy and lowers the price target from $14...

 goldman-sachs-maintains-buy-on-teladoc-health-lowers-price-target-to-10

Goldman Sachs analyst David Roman maintains Teladoc Health (NYSE:TDOC) with a Buy and lowers the price target from $13 to $10.

 stifel-maintains-hold-on-teladoc-health-lowers-price-target-to-8

Stifel analyst David Grossman maintains Teladoc Health (NYSE:TDOC) with a Hold and lowers the price target from $9 to $8.

 evercore-isi-group-maintains-in-line-on-teladoc-health-lowers-price-target-to-7

Evercore ISI Group analyst Elizabeth Anderson maintains Teladoc Health (NYSE:TDOC) with a In-Line and lowers the price targe...

 needham-reiterates-hold-on-teladoc-healthto-hold

Needham analyst Ryan MacDonald reiterates Teladoc Health (NYSE:TDOC) from Hold to Hold.

 correction-teladoc-health-q1-adj-eps-019-beats-034-estimate-sales-62940m-beat-61929m-estimate

Teladoc Health (NYSE:TDOC) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.34) ...

 teladoc-health-stock-slides-on-q1-earnings-as-company-cuts-fy25-guidance

Teladoc reports first-quarter revenue of $629.4 million, beating the consensus estimate of $619.29 million, according to Benzin...

 teladoc-health-lowers-fy2025-gaap-eps-guidance-from-110-050-to-140-090-vs-093-est-affirms-fy2025-sales-guidance-of-247b-258b-vs-252b-est

Teladoc Health (NYSE:TDOC) lowers FY2025 GAAP EPS guidance from $(1.10)-$(0.50) to $(1.40)-$(0.90) vs $(0.93) analyst estimate....

 teladoc-health-acquires-uplift-in-all-cash-transaction-for-30m

Teladoc Health acquired UpLift in an all-cash transaction for $30 million, with up to $15 million in additional contingent earn...

 citigroup-maintains-neutral-on-teladoc-health-lowers-price-target-to-875

Citigroup analyst Daniel Grosslight maintains Teladoc Health (NYSE:TDOC) with a Neutral and lowers the price target from $11...

 jefferies-maintains-hold-on-teladoc-health-lowers-price-target-to-8

Jefferies analyst Glen Santangelo maintains Teladoc Health (NYSE:TDOC) with a Hold and lowers the price target from $10 to $8.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION